✦ LIBER ✦

The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium

✍ Scribed by Jugrin, A.V.; Lamotte, M.; Malfait, M.; Vandebrouck, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Insulin D

✍ Ramirez de Arellano, A.; Orozco-Beltran, D.; Mezquita-Raya, P.; Pérez, A.; Galan 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Effectiveness of Insulin Degludec C

✍ Evans, M.; Chubb, B.; Christensen, T.; Gundgaard, J.; Wolden, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Effectiveness of Insulin Degludec C

✍ Chubb, B.; Evans, M.; Wolden, M.; Christensen, T.; Gundgaard, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-effectiveness of insulin degludec c

✍ Evans, M.; Wolden, M.; Gundgaard, J.; Chubb, B.; Christensen, T. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB

PDB40 COST-UTILITY OF BIPHASIC INSULIN A

✍ D Szmurlo; A Gurda-Duda; P Rys; J Rutkowski; I Skrzekowska-Baran; R Plisko; M Wl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The Cost-Utility of Fidaxomicin as Compa

✍ Lamotte, M.; Vellopoulou, K.; Richir, K.; Smets, J.; Grabe, K.; Coppens, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB